INIS
receptors
100%
estrogens
100%
tamoxifen
100%
growth factors
41%
cancer
33%
concentration
25%
breasts
25%
levels
16%
growth
16%
surfaces
16%
risks
16%
comparative evaluations
16%
chains
16%
charges
16%
induction
16%
metabolites
16%
estradiol
16%
carboxylic acids
16%
rats
8%
drugs
8%
molecules
8%
in vitro
8%
genes
8%
control
8%
women
8%
amino acids
8%
computers
8%
mutants
8%
uterus
8%
molecular models
8%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Antiestrogen
100%
Transforming Growth Factor
71%
Estrogen
57%
Raloxifene
57%
Diethylstilbestrol
28%
Aspartic Acid
28%
Acid
28%
4 (1,2 Diphenyl 1 Butenyl)cinnamic Acid
28%
Breast Cancer
14%
Malignant Neoplasm
14%
Active Metabolite
14%
Glycine
14%
Estrogen Receptor Positive Breast Cancer
14%
Afimoxifene
14%
Western Blot
14%
Endometrium Cancer
14%
Drug
14%
Tamoxifen Derivative
14%
Molecular Modeling
14%
Rat
14%
Incidence
14%
Neuroscience
Estrogen Receptor
100%
Tamoxifen
100%
Antiestrogen
100%
Transforming Growth Factor
62%
Estrogens
50%
Raloxifene
50%
Aspartic Acid
25%
Diethylstilbestrol
25%
Cell Line
12%
In Vitro
12%
Gene
12%
Molecular Model
12%
Amino Acids
12%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
100%
Drug Mechanism
100%
Transforming Growth Factor
62%
Raloxifene
50%
Estradiol
25%
Growth
25%
Wild Type
12%
Nested Gene
12%
Molecule
12%
Molecular Model
12%
Surface Charge
12%
Genetic Code
12%
Surface Property
12%
Contrast
12%
Rat
12%
Incidence
12%
Mutant
12%
Amino Acids
12%